Substandard medicines pose a serious public health risk, especially in the developing
world. Produced by licensed manufacturers, these medicines are the product of poor …

Substandard and falsified medicines are a global health concern negatively affecting
individuals, the public, the pharmaceutical industry and governments all over the world. This …

The circulation of substandard medicines in the developing world is a serious clinical and
public health concern. Problems include under or over concentration of ingredients …

1. Spurious/falsely labelled/falsified/counterfeit (SFFC) medicines [Internet]. Geneva: World
Health Organization; 2012. Available from: http://www. who. int/medicines/services …

Executive summary The illegal trade of substandard and falsified (SF) medical products
(also known as counterfeit pharmaceuticals, medicines or drugs) is a global challenge. It …

Despite the efforts of national and international regulatory agencies and organizations,
presence of substandard and counterfeit drugs in developing countries' markets continues to …

A vicious circle links lack of equitable access to health to the supply of poor-quality
medicines, which amount to one-tenth of medicines available in low-and middle-income …

Background Malaria is a deadly parasitic disease that affects more than 3 billion people
worldwide, in predominantly resource-poor countries. Despite malaria being preventable …

Poor-quality medicines are the cause of many public health and socioeconomic problems.
We conducted a review to acquire an overview of the situation concerning such medicines in …

Objective: The objective of this review is to produce evidence on the prevalence and trends
in the availability of substandard and counterfeit antimicrobials in the global market and its …